Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nakajima, H. et al. New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J. Antibiot. (Tokyo) 49, 1204–1211 (1996).
Nakajima, H. et al. New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. (Tokyo) 49, 1196–1203 (1996).
Nakajima, H., Takase, S., Terano, H. & Tanaka, H. New antitumor substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465. J. Antibiot. (Tokyo) 50, 96–99 (1997).
Albert, B. J., Sivaramakrishnan, A., Naka, T., Czaicki, N. L. & Koide, K. Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue. J. Am. Chem. Soc. 129, 2648–2659 (2007).
Motoyoshi, H. et al. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes. Biosci. Biotechnol. Biochem. 68, 2178–2182 (2004).
Kaida, D. et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol. 3, 576–583 (2007).
Liu, X. et al. Genomics-guided discovery of thailanstatins A, B and C as pre-mRNA splicing inhibitors and anti-proliferative agents from Burkholderia thailandensis MSMB43. J. Nat. Prod. doi:10.1021/np300913h (2013).
Wardas, W., Lipska, I. & Bober, K. TLC fractionation and visualization of selected phenolic compounds applied as drugs. Acta. Pol. Pharm. 57, 15–21 (2000).
Lange, G. L. & Lee, M. 13C NMR determination of the configuration of methyl-substituted double bonds in medium- and large-ring terpenoids. Magn. Res. Chem. 24, 656–658 (1986).
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Osman, S. et al. Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464. Chemistry 17, 895–904 (2011).
Acknowledgements
This work was supported in part by a Catalyst Award from the University of Wisconsin–Milwaukee Research Foundation and a grant from the US National Institute of Health (R01 CA152212).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Liu, X., Biswas, S., Tang, GL. et al. Isolation and characterization of spliceostatin B, a new analogue of FR901464, from Pseudomonas sp. No. 2663. J Antibiot 66, 555–558 (2013). https://doi.org/10.1038/ja.2013.38
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2013.38
Keywords
This article is cited by
-
Two new spliceostatin analogs from the strain Pseudomonas sp. HS-NF-1408
The Journal of Antibiotics (2018)